The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the "burden" on ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of ...

The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 ...

Dr Patrick Moore, chief investigator of the study and National Institute for Health and Care Research (NIHR) director in the ...

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing ...

A randomised clinical trial of an mRNA vaccine against norovirus will be launched in the UK within the next two weeks, it has ...

This isn’t just about patients getting ill. A vaccine could also help prevent healthcare staff absences, with current NHS ...

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.